Intraday BUY SELL Signals
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
iShares MSCI EAFE Min Vol Factor ETF
Price$86.28
Change-$0.02 (-0.02%)
Volume$5.23K
Net Assets5.17B
EFAV vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Dec 05, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a Buy and GSK is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 39 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 87 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 32% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 52% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 76% | 2 days ago 60% |
| Declines ODDS (%) | 15 days ago 76% | 15 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 42% |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 49% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with TEF. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then TEF could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | +0.28% | ||
| TEF - EFAV | 57% Loosely correlated | +0.24% | ||
| HLN - EFAV | 56% Loosely correlated | -1.65% | ||
| GSK - EFAV | 56% Loosely correlated | +1.45% | ||
| SAN - EFAV | 55% Loosely correlated | -0.64% | ||
| AZN - EFAV | 55% Loosely correlated | +0.75% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y